2022 annual financial data
Dermata Therapeutics 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -9,674,486 USD and net income was -9,610,913 USD.
Operating cash flow was -8,834,164 USD.
Get free Dermata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,674,486 USD
- Net income
- -9,610,913 USD
- Operating cash flow
- -8,834,164 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Dermata Therapeutics financial years